Evaluation of Tear Meniscus Dynamics Using Anterior Segment Swept-Source Optical Coherence Tomography After Topical Solution Instillation for Dry Eye

Purpose: To investigate tear meniscus dynamics using anterior segment swept-source optical coherence tomography (SS-OCT) after the instillation of topical solutions for dry eye. Design: Prospective, observational, cross-sectional study. Methods: Thirty-six healthy subjects (28 men and 8 women; mean age, 34.4 ± 6.7 years) were enrolled in this study. The lower tear meniscus height, tear meniscus area, and tear meniscus volume were assessed using anterior SS-OCT. After baseline measurements, 40 &mgr;L of 0.1% sodium hyaluronate, 0.3% sodium hyaluronate, 3% diquafosol ophthalmic solution, or 2% rebamipide ophthalmic solution was instilled in one eye of 10 subjects each, whereas 40 &mgr;L saline was instilled in the other eye. Tear meniscus measurements were obtained using SS-OCT at 30 seconds and 1, 3, 5, 10, 15, 20, and 30 minutes after instillation. Results: The tear meniscus measurements showed a significant increase until 1, 3, 10, 10, and 3 minutes after the instillation of saline, 0.1% sodium hyaluronate, 0.3% sodium hyaluronate, 3% diquafosol, and 2% rebamipide, respectively, compared with the baseline levels (P < 0.05). Compared with those after saline instillation, the tear meniscus measurements were significantly higher until 30 seconds and 3, 30, and 15 minutes after the instillation of 0.1% sodium hyaluronate, 0.3% sodium hyaluronate, 3% diquafosol, and 2% rebamipide, respectively (P < 0.05). Conclusions: The instillation of ophthalmic solutions for the treatment of dry eye greatly increased tear meniscus measurements in healthy subjects. Thus, SS-OCT can be a practical tool for the quantitative evaluation of early-phase tear fluid dynamics.

[1]  S. Kishi,et al.  Rebamipide ophthalmic suspension for the treatment of dry eye syndrome: a critical appraisal , 2014, Clinical ophthalmology.

[2]  H. Shinohara,et al.  Rebamipide increases the mucin-like glycoprotein production in corneal epithelial cells. , 2012, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[3]  Jianhua Wang,et al.  Repeated measurements of dynamic tear distribution on the ocular surface after instillation of artificial tears. , 2006, Investigative ophthalmology & visual science.

[4]  T. Fujihara,et al.  INS365 suppresses loss of corneal epithelial integrity by secretion of mucin-like glycoprotein in a rabbit short-term dry eye model. , 2002, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[5]  Min-Hsiu Shih,et al.  Effect of artificial tears on corneal surface regularity, contrast sensitivity, and glare disability in dry eyes. , 2002, Ophthalmology.

[6]  K. Tsubota,et al.  The quantitative detection of blurring of vision after eyedrop instillation using a functional visual acuity system , 2009, Acta ophthalmologica.

[7]  K. Tsubota,et al.  A randomised, double-masked comparison study of diquafosol versus sodium hyaluronate ophthalmic solutions in dry eye patients , 2012, British Journal of Ophthalmology.

[8]  S. Kinoshita,et al.  Facilitation of tear fluid secretion by 3% diquafosol ophthalmic solution in normal human eyes. , 2014, American journal of ophthalmology.

[9]  Satoru Yamagami,et al.  Tear meniscus evaluation by anterior segment swept-source optical coherence tomography. , 2012, American journal of ophthalmology.

[10]  Yansui Li,et al.  Rabbit conjunctival epithelium transports fluid, and P2Y2(2) receptor agonists stimulate Cl(-) and fluid secretion. , 2001, American journal of physiology. Cell physiology.

[11]  F. Mantelli,et al.  Functions of ocular surface mucins in health and disease , 2008, Current opinion in allergy and clinical immunology.

[12]  J. Mainstone,et al.  Tear meniscus measurement in the diagnosis of dry eye. , 1996, Current eye research.

[13]  K. Tsubota,et al.  Sodium hyaluronate eyedrops in the treatment of dry eyes. , 1995, The British journal of ophthalmology.

[14]  T. Hamano,et al.  Sodium hyaluronate eyedrops enhance tear film stability. , 1996, Japanese journal of ophthalmology.

[15]  Naoyuki Maeda,et al.  Effect of instillation of eyedrops for dry eye on optical quality. , 2013, Investigative ophthalmology & visual science.

[16]  Fan Lu,et al.  Upper and lower tear menisci in the diagnosis of dry eye. , 2009, Investigative ophthalmology & visual science.

[17]  M. Nakamura,et al.  Combined effects of hyaluronan and fibronectin on corneal epithelial wound closure of rabbit in vivo. , 1994, Current eye research.

[18]  K. Tsubota,et al.  Tear evaporation from the ocular surface. , 1992, Investigative ophthalmology & visual science.

[19]  Christophe Baudouin,et al.  The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). , 2007, The ocular surface.

[20]  K. Shimizu,et al.  Clinical evaluation of the additive effect of diquafosol tetrasodium on sodium hyaluronate monotherapy in patients with dry eye syndrome: a prospective, randomized, multicenter study , 2012, Eye.

[21]  Geunyoung Yoon,et al.  Noninvasive, Objective, Multimodal Tear Dynamics Evaluation of 5 Over-the-Counter Tear Drops in a Randomized Controlled Trial , 2012, Cornea.

[22]  Jianhua Wang,et al.  Reduced tear meniscus dynamics in dry eye patients with aqueous tear deficiency. , 2010, American journal of ophthalmology.

[23]  Yan Wang,et al.  Dynamic Changes in the Lower Tear Meniscus After Instillation of Artificial Tears , 2010, Cornea.

[24]  K. Tsubota,et al.  Efficacy and safety of diquafosol ophthalmic solution in patients with dry eye syndrome: a Japanese phase 2 clinical trial. , 2012, Ophthalmology.

[25]  T. Nishida,et al.  Fluorophotometric measurement of the precorneal residence time of topically applied hyaluronic acid , 2007, British Journal of Ophthalmology.

[26]  David Huang,et al.  Reproducibility of tear meniscus measurement by Fourier-domain optical coherence tomography: a pilot study. , 2008, Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye.

[27]  H. Shinohara,et al.  Rebamipide increases mucin-like substance contents and periodic acid Schiff reagent-positive cells density in normal rabbits. , 2012, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[28]  Alejandro Cerviño,et al.  Comparison of two artificial tear formulations for dry eye through high‐resolution optical coherence tomography , 2011, Clinical & experimental optometry.

[29]  Murat Dogru,et al.  Application of visante optical coherence tomography tear meniscus height measurement in the diagnosis of dry eye disease. , 2010, Ophthalmology.

[30]  Changyong Feng,et al.  Relationships between central tear film thickness and tear menisci of the upper and lower eyelids. , 2006, Investigative ophthalmology & visual science.

[31]  S. Kinoshita,et al.  A randomized, multicenter phase 3 study comparing 2% rebamipide (OPC-12759) with 0.1% sodium hyaluronate in the treatment of dry eye. , 2013, Ophthalmology.